(Q28217697)

English

A case report of a patient carrying CYP2C9*3/4 genotype with extremely low warfarin dose requirement

scientific article (publication date: June 2007)

In more languages

edit

Statements

0 references

0 references

A case report of a patient carrying CYP2C9*3/4 genotype with extremely low warfarin dose requirement (English)

0 references

1 reference

Soo Youn Lee

1

0 references

Myung Hyun Nam

series ordinal

2

0 references

June Soo Kim

series ordinal

3

0 references

Jong Won Kim

series ordinal

4

0 references

language of work or name

English

0 references

publication date

June 2007

0 references

published in

Journal of Korean Medical Science

0 references

volume

22

0 references

issue

3

0 references

page(s)

557-9

0 references

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

start time

1 January 2007

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Clinical consequences of cytochrome P450 2C9 polymorphisms

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

29 September 2017

Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

29 September 2017

Pharmacogenetics of oral anticoagulants

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

29 September 2017

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

29 September 2017

Pharmacogenetics of warfarin elimination and its clinical implications

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

29 September 2017

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

29 September 2017

Allelic and functional variability of cytochrome P4502C9.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

2 June 2018

Genetic analysis of the human cytochrome P450 CYP2C9 locus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

2 June 2018

Use of pharmacogenetics to guide warfarin therapy.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

27 November 2018

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

27 November 2018

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

27 November 2018

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

27 November 2018

The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

27 November 2018

Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693655

retrieved

27 November 2018

Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17596671

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17596671

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.3346/JKMS.2007.22.3.557

0 references

PMC publication ID

2693655

0 references

PubMed publication ID

17596671

0 references

ResearchGate publication ID

6240212

0 references

(Q28217697)

A case report of a patient carrying CYP2C9*3/4 genotype with extremely low warfarin dose requirement

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)